Skip to main content

Table 4 Univariate and multivariate analysis of PFS

From: Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study

PFS

 

Characteristic

Univariable analysis

Multivariable analysis

HR (95%CI)

P-value

HR (95%CI)

P-value

Age(< / ≥ 65 years)

0.561(0.295–1.064)

0.077

  

Gender(Male/Female)

1.192(0.670–2.121)

0.551

  

Ecog(< 2/ ≥ 2)

1.005(0.397–2.546)

0.991

  

Tumor site(Multi-sides/Right colon /Left colon/Rectum)

0..941(0.692–1.281)

0.700

  

Histologic grade(Low grade/High grade)

1.350(0.718–2.537)

0.351

  

Number of metastatic sites(Single/Multiple)

1.445(0.814–2.564)

0.209

  

MMR Status(dMMR/pMMR)

4.070(0.553–29.943)

0.168

  

Primary tumor surgery(No/Yes)

0.438(0.243–0.790)

0.006*

0.523(0.280–0.974)

0.041*

Intestinal obstruction(No/Yes)

1.657(0.739–3.716)

0.221

  

Liver metastases(No/Yes)

2.058(1.132–3.742)

0.018*

1.677(0.890–3.157)

0.109

Lung metastases(No/Yes)

0.667(0.355–1.254)

0.208

  

Peritoneal metastasis(No/Yes)

1.813(0.840–3.915)

0.130

  

Distant lymph node metastases(No/Yes)

0.702(0.364–1.353)

0.291

  

First-line medication(Chemo/Chemo + targeted therapy)

0.734(0.413–1.304)

0.291

 Â